Clinical Trial Update: REVIVE Prospective Registry Cohort Study

View source ↗

Summary

This entry provides an update on the REVIVE prospective registry cohort study investigating oropharyngeal dysphagia. The trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Dysphagia

Snippet

Sponsor: Peter Belafsky, MD | Conditions: Oropharyngeal Dysphagia | Status: NOT_YET_RECRUITING